Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Change in Inventory: 2016-2025

Historic Change in Inventory for Collegium Pharmaceutical (COLL) over the last 9 years, with Sep 2025 value amounting to -$96,000.

  • Collegium Pharmaceutical's Change in Inventory rose 98.63% to -$96,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $20,000, marking a year-over-year increase of 100.15%. This contributed to the annual value of -$13.9 million for FY2024, which is 1.71% up from last year.
  • Per Collegium Pharmaceutical's latest filing, its Change in Inventory stood at -$96,000 for Q3 2025, which was down 110.32% from $930,000 recorded in Q2 2025.
  • In the past 5 years, Collegium Pharmaceutical's Change in Inventory registered a high of $8.1 million during Q3 2023, and its lowest value of -$18.1 million during Q4 2022.
  • Over the past 3 years, Collegium Pharmaceutical's median Change in Inventory value was -$1.8 million (recorded in 2023), while the average stood at -$2.3 million.
  • In the last 5 years, Collegium Pharmaceutical's Change in Inventory slumped by 50,516.67% in 2022 and then skyrocketed by 257.01% in 2025.
  • Collegium Pharmaceutical's Change in Inventory (Quarterly) stood at $36,000 in 2021, then crashed by 50,516.67% to -$18.1 million in 2022, then soared by 90.12% to -$1.8 million in 2023, then crashed by 37.87% to -$2.5 million in 2024, then spiked by 98.63% to -$96,000 in 2025.
  • Its last three reported values are -$96,000 in Q3 2025, $930,000 for Q2 2025, and $1.7 million during Q1 2025.